Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimer's Disease

E-ISSN： 1873-4286|10|25|3141-3156

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.25, 2004-10, pp. : 3141-3156

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat Alzheimer’s disease

By Recanatini Maurizio Cavalli Andrea

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 12, 2002-12 ,pp. : 1853-1865

Informa Healthcare

Access to resources Recommend Favorite

Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease

Current Drug Metabolism, Vol. 18, Iss. 9, 2017-12 ,pp. : 842-852

Bentham Science Publishers

Access to resources Recommend Favorite

Cyclo-Oxygenase-2 Inhibitors: Rationale and Therapeutic Potential for Alzheimers Disease

By McGeer P.L.

Drugs & Aging, Vol. 17, Iss. 1, 2000-07 ,pp. : 1-11

Adis International

Access to resources Recommend Favorite

Therapeutic Potential in Alzheimer Disease

Current Medicinal Chemistry, Vol. 9, Iss. 17, 2002-09 ,pp. : 1605-1610

Bentham Science Publishers

Access to resources Recommend Favorite

Is there a rationale for the use of acetylcholinesterase inhibitors in the therapy of Alzheimer's disease?

By Benzi G. Moretti A.

European Journal of Pharmacology, Vol. 346, Iss. 1, 1998-04 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite